Novel aminopeptidase N inhibitors derived from antineoplaston AS2–5 (Part II)

Novel aminopeptidase N inhibitors derived from antineoplaston AS2–5 (Part II) Novel aminopeptidase N inhibitors derived from antineoplaston AS2–5 (Part I) Design, synthesis and primary activity evaluation of l-arginine derivatives as amino-peptidase N/CD13 inhibitors Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-l-aspartic acid as inhibitors of aminopeptidase N/CD13 Design, synthesis and biological evaluation of novel l-lysine ureido derivatives as aminopeptidase N inhibitors Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine